UPDATED on Dec. 11, 2018 with photo from the Dec, 10, 2018 ceremony.
ORIGINAL STORY: James P. Allison, Ph.D., an immunologist at The University of Texas MD Anderson Cancer Center, is in Sweden to receive the 2018 Nobel Prize in Physiology or Medicine jointly with Japanese immunologist Tasuku Honjo, M.D., Ph.D.
The pair were announced on Oct. 1 as laureates for the discovery of cancer therapies that stimulate the immune system to attack tumor cells. Treatments developed from Allison’s work have extended the lives of thousands of people with advanced disease, though certain cancers have responded better to immunotherapy than others.
Allison delivered his Nobel lecture entitled “Immune Checkpoint Blockade in Cancer Therapy: New insights, opportunities, and prospects for cures” on Dec. 7 in Stockholm.
Both Allison, 70, and Honjo, 76, made discoveries that led to the development of “checkpoint inhibitors”—drugs infused into patients to block molecules that put the brakes on T cells. By releasing these brakes, the body’s own immune system is able to fight cancer.
Each scientist will receive a Nobel medal and diploma. They will also share a nearly $1 million prize.
According to MD Anderson, Allison has been busy during Nobel Week in Sweden. On Thursday, he signed the bottom of a chair at Bistro Nobel in the Nobel Museum in Stockholm’s Old Town. The ritual is part of a traditional museum visit by Nobel winners and launches the week’s events.
Laureates traditionally donate artifacts to the Nobel Museum. Allison presented the museum with the following items:
- A vial representing 9H10, a mouse-model monoclonal antibody developed in his lab in 1995 to block CTLA-4, a protein on T cells that shuts down immune response
- A vial of ipilimumab from Bristol-Myers Squibb that was developed for human use based on Allison’s work
- The first page of a 1996 article in Science that reported the success of anti-CTLA-4 treatment in freeing T cells to attack cancer in mice
- The first page of a 2015 review in Cell that was co-authored by Padmanee Sharma, M.D., Ph.D., professor of Genitourinary Medical Oncology and Immunology at MD Anderson, who is the scientist’s longtime research collaborator and spouse
- A portrait of Allison and Sharma taken by a Dallas photographer
Allison is the first Nobel laureate for MD Anderson, where he is a professor and chair of the department of immunology. He is the executive director of the Immunotherapy Platform, which is part of MD Anderson’s Moon Shots Program—an ambitious effort to more rapidly reduce cancer deaths and suffering by developing advances in prevention, early detection and treatment based on scientific discoveries. In addition, Allison holds the Vivian L. Smith Distinguished Chair in Immunology and serves as deputy director of the David H. Koch Center for Applied Research of Genitourinary Cancers in the department of genitourinary medical oncology.
Read more about Allison in this profile published in the November 2018 issue of TMC Pulse.
An Oral History Boom: Hundreds of Groups Are Recording Veterans' Stories https://t.co/KZ7WTC1cPM via @wunc
MD Anderson Cancer Center@MDAndersonNews
ICYMI: Research shows small cell #lungcancer may respond to combination of #immunotherapy and DNA damage repair inhibitors https://t.co/eVvxKI367M #endcancer
ISU offering free legal clinic for service members and Veterans https://t.co/m8a8DfczL5 via @localnews8
Iraq, Afghanistan and Persian Gulf Veterans sought to take part in last honor flight by Omaha group https://t.co/WuwJltI2P5 via @sbstarherald
MD Anderson Cancer Center@MDAndersonNews
What happens to your body when you overeat? https://t.co/AyLIiWQACi via @focusedonhealth #endcancer
RT @UHpres: How about that...Cougars beat USF and take their 26th win of the season!
RT @UHCougarMBK: No 9/8 COOGS WIN!!! Final score presented by @thejointchiro UH moves to 2️⃣6️⃣-1️⃣ overall 1️⃣3️⃣-1️⃣ in #AmericanHoops…
RT @UHpres: Have to watch this game on IPhone... https://t.co/n7LZL6y3UD
@SylvesterTurner @RiceAthletics @ConferenceUSA @RiceWBB 💙🦉
RT @RiceAthletics: 🚨 YOU HEARD IT HERE FIRST! @HoustonTX Mayor @SylvesterTurner will be in attendance for the final @RiceWBB home game of…
Congrats @RiceWBB! 🎉 https://t.co/5tnjE0TjiM
Dr. Chonghui Cheng sits down with @BCMFromtheLabs to talk about how protein CD44 variants prompt different cancer cell behaviors. https://t.co/YOq8f7LIGs #cancer #research
Here's 10 creative ways to squeeze a workout into your busy schedule: https://t.co/4rqaXtZo0w. #HeartMonth https://t.co/b4DcazpBdO
RT @bcmgcprogram: @bcmgcprogram faculty member Michael Wangler (@mfwangler) was the featured event speaker at today’s @rarediseaseday Houst…
The Maternal and Child Health Training Program team at UTHealth is working to integrate community health workers into the spectrum of maternal and child health care. Learn more in this @TXHealthJournalstory: https://t.co/zRITDTDJVX #ManyFacesOfUTHealth